Introduction to the Theme “Development of New Drugs: Moving from the Bench to Bedside and Improved Patient Care”

Literature Cited

1. 1.

   Riederer E, Cang C, Ren D. 2023. Lysosomal ion channels: What are they good for and are they druggable targets?. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
2. 2.

   MacRae CA, Peterson RT. 2023. Zebrafish as a mainstream model for in vivo systems pharmacology and toxicology. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
3. 3.

   Krebs K, Milani L. 2023. Harnessing the power of electronic health records and genomics for drug discovery. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
4. 4.

   McNair D. 2023. Artificial intelligence and machine learning for lead-to-candidate decision-making and beyond. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
5. 5.

   World Health Organ. (WHO) 2022. HIV Fact Sheet, WHO Geneva: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
6. 6.

   Sokhela S, Lalla-Edward S, Siedner MJ, Majam M, Venter WDF. 2023. Roadmap for achieving universal antiretroviral treatment. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
7. 7.

   Javitt DC. 2023. Cognitive impairment associated with schizophrenia: from pathophysiology to treatment. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
8. 8.

   NIMH (Natl. Inst. Mental Health) 2022. Schizophrenia Fact Sheet, NIMH Bethesda, MD: https://www.nimh.nih.gov/health/statistics/schizophrenia
9. 9.

   Cory-Slechta DA, Merrill A, Sobolewski M 2023. Air pollution–related neurotoxicity across the life span. Annu. Rev. Pharmacol. Toxicol. In press
   [Google Scholar]
10. 10.

    Natl. Cancer Inst. 2022. Cancer statistics Fact Sheet, Natl. Cancer Inst. Bethesda, MD: https://www.cancer.gov/about-cancer/understanding/statistics
11. 11.

    Menter DG, Bresalier RS. 2023. An aspirin a day: new pharmacological developments and cancer chemoprevention. Annu. Rev. Pharmacol. Toxicol. In press
    [Google Scholar]